527 related articles for article (PubMed ID: 16529527)
1. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
Weisler RH; Kalali AH; Ketter TA;
J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
[TBL] [Abstract][Full Text] [Related]
3. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
Weisler RH; Keck PE; Swann AC; Cutler AJ; Ketter TA; Kalali AH;
J Clin Psychiatry; 2005 Mar; 66(3):323-30. PubMed ID: 15766298
[TBL] [Abstract][Full Text] [Related]
4. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
Ketter TA; Kalali AH; Weisler RH;
J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
Ginsberg LD
Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study.
Zhang ZJ; Kang WH; Tan QR; Li Q; Gao CG; Zhang FG; Wang HH; Ma XC; Chen C; Wang W; Guo L; Zhang YH; Yang XB; Yang GD
J Psychiatr Res; 2007; 41(3-4):360-9. PubMed ID: 16081106
[TBL] [Abstract][Full Text] [Related]
7. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
8. Predictors of response to carbamazepine extended-release capsules treatment in bipolar disorder.
Ginsberg LD
Ann Clin Psychiatry; 2006; 18 Suppl 1():23-6. PubMed ID: 16754409
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
10. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
11. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
Zhang ZJ; Kang WH; Li Q; Tan QR
J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
[TBL] [Abstract][Full Text] [Related]
12. Switching from other agents to extended-release carbamazepine in acute mania.
El-Mallakh RS; Ketter TA; Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Keck P; Swann AC; Kalali AH
Psychopharmacol Bull; 2008; 41(1):52-8. PubMed ID: 18362871
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine for acute affective episodes in bipolar disorder.
Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.
Weisler RH; Kalali AH; Cutler AJ; Gazda TD; Ginsberg L
Psychiatry (Edgmont); 2008 Mar; 5(3):35-48. PubMed ID: 22778707
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
Vasudev K; Goswami U; Kohli K
Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I
Bipolar Disord; 2015 Feb; 17(1):63-75. PubMed ID: 25056368
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of carbamazepine for bipolar disorders.
Wang PW; Ketter TA
Expert Opin Pharmacother; 2005 Dec; 6(16):2887-902. PubMed ID: 16318439
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine extended-release capsules in bipolar disorder.
Weisler RH
Neuropsychiatr Dis Treat; 2006 Mar; 2(1):3-11. PubMed ID: 19412441
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of carbamazepine extended-release capsules in patients with bipolar disorder: QD vs BID.
Ginsberg LD
Ann Clin Psychiatry; 2006; 18 Suppl 1():27-30. PubMed ID: 16754410
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and length of treatment with carbamazepine extended-release capsules in bipolar disorder.
Ginsberg LD
Ann Clin Psychiatry; 2006; 18 Suppl 1():15-8. PubMed ID: 16754407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
